Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 47.1320.797.03-63.65475.48

What is the latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS is 47.13 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202647.13
Mar202520.79
Mar20247.03
Mar2023-63.65
Mar2022475.48

How is Core EBITDA Growth of KWALITY PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 47.13
126.70
Mar2025 20.79
195.73
Mar2024 7.03
Positive
Mar2023 -63.65
Negative
Mar2022 475.48 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹3,460.3 Cr 27.5% 22.9% 203.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,155.0 Cr -0.3% -0.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr 3.1% 16.7% 39.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,479.0 Cr -1.5% -2.8% 38.7% Stock Analytics
CIPLA ₹118,027.0 Cr -0.8% 1.6% -1.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,662.0 Cr 2.9% -1.9% 0.2% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

27.5%

22.9%

203.5%

SENSEX

-1.1%

1.3%

-3.3%


You may also like the below Video Courses